FIDEL SALAZAR BRAVO: Open Payments
NPI 1649832643 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$591 in 21 payments from 13 companies in 2025. Trend: 2023 $445 · 2024 $406 · 2025 $591
Food & beverage: $496Education: $95
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $104 |
| SEAGEN INC. | 1 | $95 |
| Merck Sharp & Dohme LLC | 4 | $87 |
| Daiichi Sankyo Inc. | 2 | $59 |
| Lilly USA, LLC | 2 | $45 |
| Gilead Sciences, Inc. | 1 | $34 |
| E.R. Squibb & Sons, L.L.C. | 1 | $34 |
| ARRAY BIOPHARMA INC | 1 | $29 |
| Janssen Biotech, Inc. | 1 | $26 |
| Stemline Therapeutics Inc. | 1 | $23 |
Products named: KEYTRUDA, ENHERTU, VERZENIO, OPDIVO, DATROWAY, BRAFTOVI, DARZALEX, Orserdu.
Industry payments across FL — which companies pay providers there.
